Article
Effect of genetic risk factors and disease progression on the cerebrospinal fluid tau levels in Alzheimer's disease.
Journal of the American Geriatrics Society - 1 Oct 1997
Arai H, Terajima M, Miura M, Higuchi S, Muramatsu T, Matsushita S, Machida N, Nakagawa T, Lee V M, Trojanowski J Q, Sasaki H
Abstract excerpt
OBJECTIVE: This study was undertaken to gain insights into the clinical utility of measuring cerebrospinal fluid tau protein (CSF-tau) to aid in the diagnosis of Alzheimer's disease (AD). SETTING: AD patients from Tohoku University Hospital, Sendai Japan were sampled. SUBJECTS AND METHODS: CSF-ta...
Topics
- Age of Onset
- Aged
- Alzheimer Disease
- Apolipoproteins E
- Biomarkers
- Disease Progression
- Female
- Follow-Up Studies
- Genotype
- Humans
- Male
- Membrane Proteins
- Middle Aged
- Presenilin-1
- Risk Factors